Sagility Reports Strong Q2 FY27 Results with 22.5% YoY Revenue Growth
Sagility Ltd · Press Release · 23 Oct 2026, 12:12 am
Sagility Reports Strong Q2 FY27 Results with 22.5% YoY Revenue Growth Sagility Limited reported Q2 FY27 consolidated revenue of ₹20,321 million ($212.6 million), up 22.5% YoY (12.2% in constant currency), with organic growth at 22.2%. Adjusted EBITDA rose 23.0% YoY to ₹5,353 million, delivering a 26.3% margin. Adjusted PAT reached ₹3,254 million, up 8.1% YoY, while reported PAT expanded 13.3% to ₹2,842 million. The company secured $40.2 million in ACV, acquired Chirok Health LLC to strengthen provider RCM capabilities, and declared an interim dividend of ₹0.15 per share for the quarter ended 30th Sep'26.
Original exchange filing (PDF)
More announcements from Sagility Ltd
- The Company has made grant of stock options under the Employee Stock Options and Performance Stock Units Scheme 2026 of the Company · 14 Nov 2026
- The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 02, 2026 for Sagility BV · 03 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sagility B.V. · 03 Nov 2026
- Transcript of Earnings Call held on October 22, 2026 · 29 Oct 2026
- Communication to Shareholders regarding TDS on Interim Dividend FY2026-27 · 23 Oct 2026
- Disclosure of Investor Call Recording Q2FY27 · 23 Oct 2026
- Board approves Interim dividend for FY 2026-27 · 23 Oct 2026
- Corporate Action - Record date intimation for Interim dividend FY 2026-27 · 23 Oct 2026
